Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
74 studies found for:    Open Studies | "Eye Neoplasms"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Eye Neoplasms" (74 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting MRI in Diagnosing Solid Tumors of the Eye and Orbit
Condition: Eye Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
2 Recruiting Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Condition: Eye Cancer
Interventions: Procedure: Lymphatic Mapping;   Procedure: SLN Mapping/Biopsy
3 Not yet recruiting Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Conditions: Advanced Cancer;   Malignant Neoplasm of Breast;   Malignant Neoplasms of Bone and Articular Cartilage;   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites;   Malignant Neoplasms of Independent (Primary) Multiple Sites;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Malignant Neoplasms of Urinary Tract
Interventions: Drug: Lenvatinib;   Drug: Capecitabine
4 Recruiting The Role of Inflammation in Ocular Tumours
Condition: Ocular Melanoma
Intervention: Other: cSLO imaging
5 Recruiting Postoperative Pain in Orbital Disease and Ocular Tumor
Condition: Postoperative Pain
Intervention: Procedure: general anesthesia,orbital operation
6 Not yet recruiting Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma
Conditions: Malignant Neoplasms, Eye;   Glioblastoma;   Malignant Neoplasms, Brain;   Malignant Neoplasms, Central Nervous System
Interventions: Drug: FDG;   Procedure: PET/CT;   Procedure: MRI
7 Recruiting Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis
Condition: Uveal Melanoma
Interventions: Procedure: SIRT;   Procedure: DSM-TACE
8 Not yet recruiting G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Conditions: Acute Myeloid Leukemia;   Acute Lymphoid Leukemia;   Lymphoma;   Neuroblastoma;   Hepatoblastoma;   Retinoblastoma
Interventions: Biological: GM-CSF;   Biological: G-CSF;   Biological: GM-CSF and G-CSF
9 Not yet recruiting Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Conditions: Uveal Melanoma;   Hepatic Metastases
Interventions: Device: SIR-Spheres® Yttrium 90;   Drug: ipilimumab;   Drug: nivolumab
10 Recruiting Phase II Evaluating Endoresection of the Tumor Scar or Transpupillary Thermotherapy When Endoresection is Not Feasible After Proton Beam Therapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Conditions: Uveal Melanoma;   Melanoma, Uveal
Interventions: Procedure: Endoresection;   Procedure: Laser diode
11 Recruiting Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
Condition: Retinoblastoma
Interventions: Other: Observation;   Drug: Etoposide;   Drug: Vincristine;   Radiation: Orbital irradiation;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Procedure: Cytapheresis;   Procedure: Peripheral bood stem cell transplantation
12 Recruiting Conservative Treatments of Retinoblastoma
Conditions: Retinoblastoma;   Children;   Retinal Neoplasm
Interventions: Drug: VP16, carboplatin;   Drug: Melphalan;   Drug: VP16, carboplatin, vincristin;   Drug: Carboplatin + laser day 1 (chemothermotherapy);   Device: Laser (local treatment);   Device: cryoapplication (local treatment);   Radiation: I125 radioactive plaques (local treatment);   Drug: intravitreal Melphalan (local treatment)
13 Recruiting Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
Condition: Uveal Melanoma
Intervention: Biological: Blood sampling
14 Recruiting Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Conditions: Neuroblastoma;   Sarcoma;   Carcinoma;   Desmoplastic Small Round Cell Tumor;   Retinoblastoma;   Wilms Tumor;   Melanoma
15 Recruiting Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Adjuvant chemotherapy by Fotemustin;   Other: Intensive surveillance
16 Recruiting Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Condition: Retinoblastoma
Interventions: Drug: Carboplatin;   Drug: Maxitrol®;   Procedure: Focal Therapy;   Procedure: Plaque Radiotherapy
17 Recruiting Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Conditions: Uveal Melanoma;   Choroid Neoplasm
Intervention: Biological: ICON-1
18 Not yet recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
19 Not yet recruiting Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye
Condition: Metastatic Uveal Melanoma
Interventions: Drug: Pembrolizumab;   Drug: Entinostat
20 Not yet recruiting Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Conditions: Amblyopia;   Myopia;   Hyperopia;   Astigmatism;   Cataract;   Retinoblastoma;   Trachoma;   Xerophthalmia;   Glaucoma;   Retinopathy of Prematurity
Interventions: Device: Spot photoscreener;   Procedure: Ophthalmologic evaluation;   Procedure: Cyclopleged refraction

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years